Sigal Charles Elliott Insider Trades

Insider Trading History

Track insider trading activity for Sigal Charles Elliott. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Vir Biotechnology
Vir Biotechnology VIR
Director
Holding Value $404k 39,806 shares
Last Trade
May 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$218k 24,000 shares
$9.10
$10.16
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $417k 1,446 shares
Last Trade
May 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$630k 2,112 shares
$298.48
$288.18
Vir Biotechnology
Vir Biotechnology VIR
Director
Holding Value $323k 31,806 shares
Last Trade
May 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$79k 16,000 shares
$4.94
$10.16
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $449k 1,558 shares
Last Trade
May 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$403k 1,558 shares
$258.35
$288.18
Vir Biotechnology
Vir Biotechnology VIR
Director
Holding Value $242k 23,806 shares
Last Trade
May 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$166k 16,000 shares
$10.39
$10.16
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $1.51M 5,228 shares
Last Trade
May 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$791k 5,228 shares
$151.22
$288.18
Surface Oncology
Surface Oncology SURF
Director
Holding Value $0 0 shares
Last Trade
Sep 08, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$122k 113,636 shares
$1.07
$1.07
Vir Biotechnology
Vir Biotechnology VIR
Director
Holding Value $161k 15,806 shares
Last Trade
May 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$465k 18,081 shares
$25.74
$10.16
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $995k 3,454 shares
Last Trade
May 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$656k 3,454 shares
$189.87
$288.18
Vir Biotechnology
Vir Biotechnology VIR
Director
Holding Value $102k 10,000 shares
Last Trade
Mar 01, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$56.8k 2,500 shares
$22.73
$10.16
Vir Biotechnology
Vir Biotechnology VIR
Director
Holding Value $76.2k 7,500 shares
Last Trade
Jan 05, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$62.4k 2,500 shares
$24.96
$10.16
Vir Biotechnology
Vir Biotechnology VIR
Director
Holding Value $50.8k 5,000 shares
Last Trade
Jan 04, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$63.1k 2,500 shares
$25.25
$10.16
Vir Biotechnology
Vir Biotechnology VIR
Director
Holding Value $25.4k 2,500 shares
Last Trade
Jan 03, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$64k 2,500 shares
$25.60
$10.16
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $1.28M 4,456 shares
Last Trade
Aug 22, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.94M 8,912 shares
$217.91
$288.18
Surface Oncology
Surface Oncology SURF
Director
Holding Value $25.7k 24,000 shares
Last Trade
Jun 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.2k 24,000 shares
$2.01
$1.07
Vir Biotechnology
Vir Biotechnology VIR
Director
Holding Value $130k 12,810 shares
Last Trade
May 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$773k 32,025 shares
$24.14
$10.16
Surface Oncology
Surface Oncology SURF
Director
Holding Value $18.9k 17,700 shares
Last Trade
Jun 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$136k 17,700 shares
$7.69
$1.07
Vir Biotechnology
Vir Biotechnology VIR
Director
Holding Value $68.6k 6,748 shares
Last Trade
May 21, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$458k 10,122 shares
$45.28
$10.16
Vir Biotechnology
Vir Biotechnology VIR
Director
Holding Value $288k 28,394 shares
Last Trade
Jul 10, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.38M 28,394 shares
$48.71
$10.16
Vir Biotechnology
Vir Biotechnology VIR
Director
Holding Value $587k 57,777 shares
Last Trade
Jul 10, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.81M 57,777 shares
$48.71
$10.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up